287 related articles for article (PubMed ID: 30884976)
21. Osteopontin mediates mineralization and not osteogenic cell development in vitro.
Holm E; Gleberzon JS; Liao Y; Sørensen ES; Beier F; Hunter GK; Goldberg HA
Biochem J; 2014 Dec; 464(3):355-64. PubMed ID: 25310312
[TBL] [Abstract][Full Text] [Related]
22. Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity.
Addison WN; Azari F; Sørensen ES; Kaartinen MT; McKee MD
J Biol Chem; 2007 May; 282(21):15872-83. PubMed ID: 17383965
[TBL] [Abstract][Full Text] [Related]
23. Synergistic effect of extracellularly supplemented osteopontin and osteocalcin on stem cell proliferation, osteogenic differentiation, and angiogenic properties.
Carvalho MS; Cabral JM; da Silva CL; Vashishth D
J Cell Biochem; 2019 Apr; 120(4):6555-6569. PubMed ID: 30362184
[TBL] [Abstract][Full Text] [Related]
24. Wnt5a suppresses osteoblastic differentiation of human periodontal ligament stem cell-like cells via Ror2/JNK signaling.
Hasegawa D; Wada N; Yoshida S; Mitarai H; Arima M; Tomokiyo A; Hamano S; Sugii H; Maeda H
J Cell Physiol; 2018 Feb; 233(2):1752-1762. PubMed ID: 28681925
[TBL] [Abstract][Full Text] [Related]
25. Periodontal fibroblasts modulate proliferation and osteogenic differentiation of embryonic stem cells through production of fibroblast growth factors.
Kook SH; Jeon YM; Park SS; Lee JC
J Periodontol; 2014 Apr; 85(4):645-54. PubMed ID: 23805819
[TBL] [Abstract][Full Text] [Related]
26. Osteopontin inhibits osteoblast responsiveness through the down-regulation of focal adhesion kinase mediated by the induction of low-molecular weight protein tyrosine phosphatase.
Kusuyama J; Bandow K; Ohnishi T; Hisadome M; Shima K; Semba I; Matsuguchi T
Mol Biol Cell; 2017 May; 28(10):1326-1336. PubMed ID: 28331074
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor-2 induces osteogenic differentiation through a Runx2 activation in vascular smooth muscle cells.
Nakahara T; Sato H; Shimizu T; Tanaka T; Matsui H; Kawai-Kowase K; Sato M; Iso T; Arai M; Kurabayashi M
Biochem Biophys Res Commun; 2010 Apr; 394(2):243-8. PubMed ID: 19903460
[TBL] [Abstract][Full Text] [Related]
28. miRNA-133a-5p Inhibits the Expression of Osteoblast Differentiation-Associated Markers by Targeting the 3' UTR of RUNX2.
Zhang W; Wu Y; Shiozaki Y; Sugimoto Y; Takigawa T; Tanaka M; Matsukawa A; Ozaki T
DNA Cell Biol; 2018 Mar; 37(3):199-209. PubMed ID: 29359964
[TBL] [Abstract][Full Text] [Related]
29. Dose-dependence of PTH-related peptide-1 on the osteogenic induction of MC3T3-E1 cells in vitro.
Wang J; Li J; Yang L; Zhou Y; Wang Y
Medicine (Baltimore); 2017 Apr; 96(17):e6637. PubMed ID: 28445262
[TBL] [Abstract][Full Text] [Related]
30. Regulative Effect of Mir-205 on Osteogenic Differentiation of Bone Mesenchymal Stem Cells (BMSCs): Possible Role of SATB2/Runx2 and ERK/MAPK Pathway.
Hu N; Feng C; Jiang Y; Miao Q; Liu H
Int J Mol Sci; 2015 May; 16(5):10491-506. PubMed ID: 25961955
[TBL] [Abstract][Full Text] [Related]
31. Lactoferrin stimulates osteoblast differentiation through PKA and p38 pathways independent of lactoferrin's receptor LRP1.
Zhang W; Guo H; Jing H; Li Y; Wang X; Zhang H; Jiang L; Ren F
J Bone Miner Res; 2014; 29(5):1232-43. PubMed ID: 24877241
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of SLC41A1 magnesium transporter promotes mineralization and attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells.
Tsao YT; Shih YY; Liu YA; Liu YS; Lee OK
Stem Cell Res Ther; 2017 Feb; 8(1):39. PubMed ID: 28222767
[TBL] [Abstract][Full Text] [Related]
33. Determination of osteoprogenitor-specific promoter activity in mouse mesenchymal stem cells by recombinant adeno-associated virus transduction.
Kumar S; Mahendra G; Ponnazhagan S
Biochim Biophys Acta; 2005 Nov; 1731(2):95-103. PubMed ID: 16225939
[TBL] [Abstract][Full Text] [Related]
34. Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix.
Higuchi C; Myoui A; Hashimoto N; Kuriyama K; Yoshioka K; Yoshikawa H; Itoh K
J Bone Miner Res; 2002 Oct; 17(10):1785-94. PubMed ID: 12369782
[TBL] [Abstract][Full Text] [Related]
35. The roles of extracellular signal-regulated kinase 1/2 pathway in regulating osteogenic differentiation of murine preosteoblasts MC3T3-E1 cells on roughened titanium surfaces.
Zhuang LF; Jiang HH; Qiao SC; Appert C; Si MS; Gu YX; Lai HC
J Biomed Mater Res A; 2012 Jan; 100(1):125-33. PubMed ID: 21997903
[TBL] [Abstract][Full Text] [Related]
36. Gene expression during induced differentiation of sheep bone marrow mesenchymal stem cells into osteoblasts.
Hu Y; Tang XX; He HY
Genet Mol Res; 2013 Dec; 12(4):6527-34. PubMed ID: 24390999
[TBL] [Abstract][Full Text] [Related]
37. Roles of MAP kinases in the regulation of bone matrix gene expressions in human osteoblasts by oscillatory fluid flow.
Wu CC; Li YS; Haga JH; Wang N; Lian IY; Su FC; Usami S; Chien S
J Cell Biochem; 2006 Jun; 98(3):632-41. PubMed ID: 16440309
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effects of Nell-1 and BMP-2 on the osteogenic differentiation of myoblasts.
Cowan CM; Jiang X; Hsu T; Soo C; Zhang B; Wang JZ; Kuroda S; Wu B; Zhang Z; Zhang X; Ting K
J Bone Miner Res; 2007 Jun; 22(6):918-30. PubMed ID: 17352654
[TBL] [Abstract][Full Text] [Related]
39. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
40. Alpha ketoglutarate exerts a pro-osteogenic effect in osteoblast cell lines through activation of JNK and mTOR/S6K1/S6 signaling pathways.
Żurek A; Mizerska-Kowalska M; Sławińska-Brych A; Kaławaj K; Bojarska-Junak A; Kandefer-Szerszeń M; Zdzisińska B
Toxicol Appl Pharmacol; 2019 Jul; 374():53-64. PubMed ID: 31051157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
